123 related articles for article (PubMed ID: 22618)
1. The effect of bromocriptine on locomotor activity and cerebral catecholamines in rodents.
Dolphin AC; Jenner P; Sawaya MC; Marsden CD; Testa B
J Pharm Pharmacol; 1977 Dec; 29(12):727-34. PubMed ID: 22618
[No Abstract] [Full Text] [Related]
2. Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms.
Jenner P; Clow A; Reavill C; Theodorou A; Marsden CD
J Pharm Pharmacol; 1980 Jan; 32(1):39-44. PubMed ID: 6102125
[No Abstract] [Full Text] [Related]
3. Bromocriptine: a rather specific stimulant of dopamine receptors regulating dopamine metabolism.
Di Chiara G; Vargiu L; Porceddu ML; Gessa GL
Adv Biochem Psychopharmacol; 1977; 16():443-6. PubMed ID: 578073
[No Abstract] [Full Text] [Related]
4. Effect of muscimol, a GABA-mimetic agent, on dopamine metabolism in the mouse brain.
Biggio G; Casu M; Corda MG; Vernaleone F; Gessa GL
Life Sci; 1977 Aug; 21(4):525-31. PubMed ID: 904431
[No Abstract] [Full Text] [Related]
5. Catecholamines and their metabolites in the brain and urine of rats with experimental Parkinson's disease.
Chekhonin VP; Baklaushev VP; Kogan BM; Savchenko EA; Lebedev SV; Man'kovskaya IV; Filatova TS; Yusupova IU; Dmitrieva TB
Bull Exp Biol Med; 2000 Aug; 130(8):805-9. PubMed ID: 11177250
[TBL] [Abstract][Full Text] [Related]
6. Striatal dopamine receptors become supersensitive while rats are geven trifluoperazine for six months.
Clow A; Jenner P; Theodorou A; Marsden CD
Nature; 1979 Mar; 278(5699):59-61. PubMed ID: 570253
[No Abstract] [Full Text] [Related]
7. Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus.
Tonon G; Saiani L; Spano PF; Trabucchi M
Brain Res; 1979 Jan; 160(3):553-8. PubMed ID: 217486
[No Abstract] [Full Text] [Related]
8. Changes in rat brain monoamine turnover following chronic antidepressant administration.
Sugrue MF
Life Sci; 1980 Feb; 26(6):423-9. PubMed ID: 6154860
[No Abstract] [Full Text] [Related]
9. Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.
Koulu M; Lappalainen J; Pesonen U; Hietala J; Syvälahti E
Eur J Pharmacol; 1988 Oct; 155(3):313-6. PubMed ID: 3069483
[TBL] [Abstract][Full Text] [Related]
10. Changes in brain catecholamine metabolism during bromocriptine treatment in polycystic ovary syndrome.
Paradisi R; Grossi G; Venturoli S; Porcu E; Rocchi G; Pasquali R; Capelli M; Flamigni C
Horm Res; 1993; 39(5-6):223-8. PubMed ID: 8314207
[TBL] [Abstract][Full Text] [Related]
11. Behavioural, biochemical and electrophysiological studies on the motor depressant and stimulant effects of bromocriptine.
Jackson DM; Martin LP; Larsson LG; Cox RF; Waszczak BL; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):290-9. PubMed ID: 2126347
[TBL] [Abstract][Full Text] [Related]
12. Neurochemical investigation of an endogenous model of the "hyperkinetic syndrome" in a hybrid dog.
Bareggi SR; Becker RE; Ginsburg BE; Genovese E
Life Sci; 1979 Feb; 24(6):481-8. PubMed ID: 34769
[No Abstract] [Full Text] [Related]
13. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
[TBL] [Abstract][Full Text] [Related]
14. Effects of rubidium and cesium on central catecholamines and locomotor behavior in rats.
Rastogi RB; Singhal RL; Lapierre YD
J Neurochem; 1980 Jun; 34(6):1764-7. PubMed ID: 7381502
[No Abstract] [Full Text] [Related]
15. Stimulation of "regulatory" dopamine receptors by bromocriptine (CB-154).
Di Chiara G; Porceddu ML; Vargiu L; Gessa GL
Pharmacology; 1978; 16 Suppl 1():135-42. PubMed ID: 643899
[TBL] [Abstract][Full Text] [Related]
16. Changes of serotonin and catecholamines are related to pharmacokinetic alterations of clomipramine in rat brain.
Fujita K; Kobayashi A; Suzuki S; Nakazawa K
Eur J Pharmacol; 1991 Nov; 204(3):227-33. PubMed ID: 1723048
[TBL] [Abstract][Full Text] [Related]
17. Synaptosomal uptake of norepinephrine and 5-hydroxytryptamine and synthesis of catecholamines during benzodiazepine treatment.
Rastogi RB; Lapierre YD; Singhal RL
Can J Physiol Pharmacol; 1978 Oct; 56(5):777-84. PubMed ID: 30525
[No Abstract] [Full Text] [Related]
18. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats.
Pycock CJ; Kerwin RW; Carter CJ
Nature; 1980 Jul; 286(5768):74-6. PubMed ID: 7393327
[No Abstract] [Full Text] [Related]
19. Effects of disulfiram and chloral hydrate on the metabolism of catecholamines in rat liver and brain.
Berger D; Weiner H
Biochem Pharmacol; 1977 Apr; 26(8):741-7. PubMed ID: 856206
[No Abstract] [Full Text] [Related]
20. Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase.
Schwarcz R; Fuxe K; Agnati LF; Gustafsson JA
Life Sci; 1978 Aug; 23(5):465-9. PubMed ID: 692269
[No Abstract] [Full Text] [Related]
[Next] [New Search]
